Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.

NCT02461888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Cyclophosphamide
DRUG: Dexamethasone

Sponsor

University of Leeds

Collaborators

[object Object]
[object Object]